Your browser is no longer supported. Please, upgrade your browser.
Settings
PTLA Portola Pharmaceuticals, Inc. daily Stock Chart
PTLA [NASD]
Portola Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-4.15 Insider Own0.60% Shs Outstand77.59M Perf Week-4.32%
Market Cap1.01B Forward P/E- EPS next Y-3.23 Insider Trans-1.06% Shs Float76.64M Perf Month-5.02%
Income-282.50M PEG- EPS next Q-0.88 Inst Own- Short Float22.55% Perf Quarter-55.01%
Sales102.70M P/S9.87 EPS this Y-10.30% Inst Trans-0.44% Short Ratio11.31 Perf Half Y-54.67%
Book/sh2.92 P/B4.47 EPS next Y12.50% ROA-65.30% Target Price23.33 Perf Year-57.88%
Cash/sh6.15 P/C2.13 EPS next 5Y- ROE-322.60% 52W Range12.62 - 37.95 Perf YTD-45.31%
Dividend- P/FCF- EPS past 5Y-7.80% ROI- 52W High-66.32% Beta1.93
Dividend %- Quick Ratio5.90 Sales past 5Y30.70% Gross Margin77.50% 52W Low1.23% ATR0.59
Employees324 Current Ratio5.90 Sales Q/Q159.20% Oper. Margin- RSI (14)27.80 Volatility2.62% 4.38%
OptionableYes Debt/Eq1.32 EPS Q/Q36.90% Profit Margin- Rel Volume0.75 Prev Close13.06
ShortableYes LT Debt/Eq1.20 EarningsFeb 26 AMC Payout- Avg Volume1.53M Price12.78
Recom2.30 SMA20-5.30% SMA50-30.23% SMA200-50.19% Volume647,337 Change-2.14%
Jan-10-20Downgrade Oppenheimer Outperform → Perform
Nov-08-19Initiated Goldman Neutral $35
Aug-05-19Resumed Credit Suisse Neutral $35
Jul-10-19Resumed Credit Suisse Neutral
Aug-27-18Upgrade Credit Suisse Underperform → Neutral
Aug-10-18Downgrade Credit Suisse Neutral → Underperform
Mar-01-18Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-01-17Initiated Goldman Buy $75
Aug-24-17Upgrade Credit Suisse Neutral → Outperform
Jun-26-17Reiterated Morgan Stanley Overweight $50 → $70
Jun-26-17Reiterated Citigroup Buy $51 → $78
Feb-24-17Upgrade Oppenheimer Perform → Outperform
Jan-03-17Upgrade Citigroup Neutral → Buy
Dec-27-16Reiterated Credit Suisse Outperform $20 → $29
Aug-19-16Downgrade Citigroup Buy → Neutral
May-31-16Downgrade Credit Suisse Outperform → Neutral $33 → $30
Mar-28-16Reiterated Credit Suisse Outperform $47 → $34
Mar-28-16Downgrade Goldman Buy → Neutral $65 → $30
Dec-18-15Initiated Goldman Buy
Feb-25-20 12:15PM  Portola Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Portola Pharmaceuticals, Inc. To Contact The Firm Newsfile
10:45AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PTLA, GERN and LK ACCESSWIRE
Feb-24-20 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, PTLA, QD, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
04:38PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA GlobeNewswire
10:50AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FSCT, PTLA and LK ACCESSWIRE
09:13AM  PORTOLA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Portola Pharmaceuticals, Inc. To Contact The Firm Newsfile
08:00AM  Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences PR Newswire
Feb-23-20 11:00AM  CLASS ACTION UPDATE for PTLA, QD and LK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Feb-21-20 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS FSCT, PTLA, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
Feb-20-20 10:45AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SSL, OPRA and PTLA ACCESSWIRE
10:15AM  ROSEN, NATIONAL TRIAL LAWYERS, Reminds Portola Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action PTLA GlobeNewswire
Feb-19-20 11:57PM  Portola Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Portola Pharmaceuticals, Inc. To Contact The Firm Newsfile
10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, MAT, PTLA, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
06:40PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FSCT, OPRA and PTLA ACCESSWIRE
04:56PM  PTLA DEADLINE: Pawar Law Group Reminds Investors of March 16 Deadline in Securities Class Action Lawsuit Against Portola Pharmaceuticals, Inc. PTLA GlobeNewswire
01:00PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Forescout Technologies, 500.com, Portola Pharmaceuticals, and Qudian and Encourages Investors to Contact the Firm GlobeNewswire
12:45PM  CLASS ACTION UPDATE for PTLA, GERN and BYND: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:28AM  INVESTOR ALERT - Portola Pharmaceuticals Inc. (PTLA) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $100K of Class Action and Lead Deadline: March 16, 2020 ACCESSWIRE
Feb-18-20 10:50PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of FSCT, MAT, PTLA and TCNNF GlobeNewswire
06:19PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA GlobeNewswire
01:25PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GDOT, PTLA and GERN ACCESSWIRE
01:00PM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Portola Pharmaceuticals, Inc. (PTLA) ACCESSWIRE
11:30AM  SHAREHOLDER ALERT: GDOT PTLA GERN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:33AM  PORTOLA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Portola Pharmaceuticals, Inc. To Contact The Firm Newsfile
Feb-17-20 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS FSCT, MAT, PTLA, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
11:45AM  CLASS ACTION UPDATE for SSL, OPRA and PTLA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
09:21AM  PTLA LOSSES ALERT: Bernstein Liebhard Encourages Investors With Losses in Portola Pharmaceuticals Inc. to Contact the Firm and Reminds Them of an Important Filing Deadline ACCESSWIRE
Feb-16-20 10:20AM  SHAREHOLDER ALERT: SSL PTLA WBK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
Feb-15-20 03:00PM  ROSEN, A LEADING INVESTOR FIRM, Reminds Portola Pharmaceuticals, Inc. Investors of Important March 16th Deadline in Securities Class Action PTLA Business Wire
Feb-14-20 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, MAT, PTLA, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
03:50PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PTLA, QD and BYND ACCESSWIRE
03:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA ACCESSWIRE
01:50PM  PTLA LOSSES ALERT: Bernstein Liebhard Encourages Investors With Losses in Portola Pharmaceuticals Inc. to Contact the Firm and Reminds Them of an Important Filing Deadline ACCESSWIRE
01:45PM  CLASS ACTION UPDATE for GDOT, SSL and PTLA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
12:30PM  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Portola Pharmaceuticals, Inc. ACCESSWIRE
09:50AM  SHAREHOLDER ALERT: SSL FSCT PTLA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
09:18AM  Portola Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Portola Pharmaceuticals, Inc. To Contact The Firm Newsfile
Feb-13-20 06:15PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of EXC, PTLA and BYND ACCESSWIRE
04:05PM  PTLA LOSSES ALERT: Bernstein Liebhard Encourages Investors With Losses in Portola Pharmaceuticals Inc. to Contact the Firm and Reminds Them of an Important Filing Deadline ACCESSWIRE
Feb-12-20 07:30PM  PORTOLA SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Portola Pharmaceuticals, Inc. - PTLA Business Wire
04:40PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SSL, FSCT and PTLA ACCESSWIRE
04:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA ACCESSWIRE
02:22PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Trulieve Cannabis, Forescout Technologies, 500.com, and Portola Pharmaceuticals and Encourages Investors to Contact the Firm GlobeNewswire
01:40PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FSCT, PTLA and BYND ACCESSWIRE
12:30PM  DEADLINE ALERT for EXC, TCNNF, WBAI, and PTLA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:13AM  Portola Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Portola Pharmaceuticals, Inc. To Contact The Firm Newsfile
10:58AM  ROSEN, NATIONAL INVESTOR COUNSEL, Reminds Portola Pharmaceuticals, Inc. Investors of Important March 16th Deadline in Securities Class Action PTLA GlobeNewswire
10:50AM  CLASS ACTION UPDATE for FSCT, PTLA and WBK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:00AM  INVESTOR ALERT - Portola Pharmaceuticals Inc. (PTLA) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: March 16, 2020 GlobeNewswire
08:00AM  Portola Pharmaceuticals to Announce Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26, 2020 PR Newswire
Feb-11-20 01:40PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SSL, PTLA and GERN ACCESSWIRE
01:15PM  Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Actions Against Portola Pharmaceuticals, Inc. (PTLA) PR Newswire
12:01PM  Portola Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Portola Pharmaceuticals, Inc. To Contact The Firm Newsfile
Feb-10-20 07:15PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GDOT, PTLA and WBK ACCESSWIRE +7.45%
04:23PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA GlobeNewswire
04:05PM  SHAREHOLDER ALERT: FSCT PTLA QD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
03:42PM  Shareholder Alert: Robbins LLP Reminds Investors Portola Pharmaceuticals, Inc. (PTLA) Sued for Misleading Shareholders Business Wire
12:30PM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Portola Pharmaceuticals, Inc. (PTLA) GlobeNewswire
11:30AM  CLASS ACTION UPDATE for FSCT, PTLA and GERN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:56AM  PTLA DEADLINE NOTICE: Pawar Law Group Reminds Investors of March 16 Deadline in Securities Class Action Lawsuit Against Portola Pharmaceuticals, Inc. PTLA GlobeNewswire
09:00AM  Implied Volatility Surging for Portola Pharmaceuticals (PTLA) Stock Options Zacks
Feb-09-20 10:25AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ADMS, OPRA and PTLA ACCESSWIRE
Feb-07-20 06:00PM  Saxena White P.A. Files New Securities Fraud Class Action Complaint Against Portola Pharmaceuticals, Inc. with Expanded Class Period GlobeNewswire
04:35PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GDOT, PTLA and QD ACCESSWIRE
02:10PM  SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Portola Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:30PM  CLASS ACTION UPDATE for ADMS, GDOT and PTLA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Feb-06-20 11:35PM  PORTOLA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Portola Pharmaceuticals, Inc. To Contact The Firm Newsfile
04:30PM  Wolf Haldenstein Reminds Investors In Portola Pharmaceuticals, Inc. That A Securities Class Action Has Been Filed PR Newswire
01:50PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PTLA, GERN and BYND ACCESSWIRE
01:35PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA ACCESSWIRE
01:00PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Portola Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:00PM  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Portola Pharmaceuticals, Inc. GlobeNewswire
09:53AM  INVESTOR ALERT - Portola Pharmaceuticals Inc. (PTLA) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $100K of Class Action and Lead Plaintiff Deadline: March 16, 2020 ACCESSWIRE
Feb-05-20 09:16PM  The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Portola Pharmaceuticals, Inc. (PLT) GlobeNewswire
06:45PM  CLASS ACTION UPDATE for EXC, PTLA and QD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
06:00PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against 500.com, Portola Pharmaceuticals, Qudian, and Geron Corporation and Encourages Investors to Contact the Firm GlobeNewswire
03:15PM  SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Portola Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:40PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ADMS, XYF and PTLA ACCESSWIRE
12:13PM  PTLA ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Reminds Portola Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action PTLA GlobeNewswire
11:00AM  SHAREHOLDER ALERT: XYF BZUN PTLA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
05:17AM  Did Changing Sentiment Drive Portola Pharmaceuticals's (NASDAQ:PTLA) Share Price Down A Worrying 53%? Simply Wall St.
Feb-04-20 10:17PM  PORTOLA DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Portola Pharmaceuticals, Inc. to Contact the Firm Business Wire +6.50%
08:40PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ADMS, FSCT and PTLA ACCESSWIRE
08:10PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Portola Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:57PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA GlobeNewswire
12:30PM  SHAREHOLDER ALERT: ADMS PTLA GERN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
12:22PM  PORTOLA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Portola Pharmaceuticals, Inc. To Contact The Firm Newsfile
01:04AM  PORTOLA DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Portola Pharmaceuticals, Inc. To Contact The Firm GlobeNewswire
Feb-03-20 07:55PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MMSI, PTLA and QD ACCESSWIRE +5.86%
07:10PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Portola Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
03:45PM  SHAREHOLDER ALERT: ADMS GDOT PTLA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
11:15AM  WeissLaw LLP: Portola Pharmaceuticals, Inc. is the Subject of a Legal Investigation PR Newswire
11:00AM  PTLA DEADLINE: Pawar Law Group Reminds Investors of Deadline in Securities Class Action Lawsuit Against Portola Pharmaceuticals, Inc. PTLA GlobeNewswire
10:45AM  CLASS ACTION UPDATE for BZUN, OPRA and PTLA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
08:30AM  Portola Pharmaceuticals Appoints Rajiv Patni, M.D., as Executive Vice President and Chief Medical Officer PR Newswire
Feb-01-20 07:25AM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Portola Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Jan-31-20 06:15PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of EXC, PTLA and GERN ACCESSWIRE
04:55PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Portola Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
03:15PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BZUN, PTLA and QD ACCESSWIRE
02:45PM  ROSEN, A LEADING LAW FIRM, Reminds Portola Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action PTLA Business Wire
Portola Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes novel therapeutics in the areas of thrombosis and other hematologic disorders and inflammation in the United States. The company offers Andexxa, an antidote for patients treated with rivaroxaban and apixaban when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding; and Bevyxxa (betrixaban), an oral, once-daily Factor Xa inhibitor for the prevention of venous thromboembolism in adult patients hospitalized for an acute medical illness. It is also advancing cerdulatinib, a dual spleen tyrosine kinase and janus kinases inhibitor in development for the treatment of hematologic cancers. In addition, the company is developing PRT2761, a Syk inhibitor that has completed Phase II clinical trial for the treatment for allergic conjunctivitis. Portola Pharmaceuticals, Inc. has collaboration agreements with Bristol-Myers Squibb; Pfizer Inc.; Bayer Pharma, AG; Janssen Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; Millennium Pharmaceuticals, Inc.; SRX Cardio; LLC; Ora; and Astellas Pharma Inc. The company was founded in 2003 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RENTON HOLLINGSDirectorNov 01Option Exercise9.005,00045,00018,194Nov 04 07:32 PM
RENTON HOLLINGSDirectorNov 01Sale30.005,000150,00013,194Nov 04 07:32 PM
RENTON HOLLINGSDirectorAug 08Option Exercise9.005,00045,00018,194Aug 09 06:51 PM
RENTON HOLLINGSDirectorAug 08Sale30.005,000150,00013,194Aug 09 06:51 PM
RENTON HOLLINGSDirectorApr 15Option Exercise9.005,00045,00014,000Apr 16 07:44 PM
RENTON HOLLINGSDirectorApr 15Sale34.455,000172,2509,000Apr 16 07:44 PM
Dier MardiEVP, CFO & CBOApr 04Sale37.3940,4861,513,82466,733Apr 08 07:03 PM
Wolff Henry WardDirectorMar 12Option Exercise5.105,00025,50015,766Mar 14 09:17 PM